Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Peptide Chemistry

Background:

• CXCR4 antagonists are crucial in various diseases.
• Previous studies identified cyclic pentapeptides as CXCR4 antagonists.
• Optimization of these antagonists is needed for improved efficacy.

Purpose of the Study:

• To conduct structure-activity relationship (SAR) studies on CXCR4 antagonists.
• To optimize side-chain functional groups of cyclic pentapeptides.
• To develop novel cyclic pentapeptide leads with improved pharmacophores.

Main Methods:

• Utilizing cyclic pentapeptide libraries for SAR analysis.
• Synthesizing conformationally constrained analogues.
• Introducing a novel pharmacophore into the peptide structure.

Main Results:

• Optimized side-chain functional groups in CXCR4 antagonists.
• Identified key structural modifications for enhanced activity.
• Developed a new class of cyclic pentapeptides with a novel pharmacophore.

Conclusions:

• Structure-activity relationship studies successfully refined CXCR4 antagonists.
• The introduction of a novel pharmacophore yielded promising new cyclic pentapeptide leads.
• These findings pave the way for developing more effective CXCR4-targeting therapeutics.